IndyGeneUS Bio

Cover Block

Field	Value
Name	IndyGeneUS Bio
Tagline	Blockchain-encrypted genomic data platform for health equity, clinical trials, and drug discovery in underrepresented populations
Headquarters	Baltimore, Maryland, USA
Stage	Seed
Business Model	B2B
Industry	Healthtech
Technology Type	Biotech / Life Sciences
Geography	North America (with Africa expansion)
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding Label	Seed
Total Disclosed	At least $3.5M across pre-seed rounds [Crunchbase; GenomeWeb]

Links

• LinkedIn: https://www.linkedin.com/company/indygeneus
• Technical.ly profile: https://technical.ly/company/indygeneus/

Executive Summary

IndyGeneUS Bio is building a blockchain-encrypted repository of indigenous and diasporic African and Afro-Latin clinical and multi-omics data intended to feed disease prevention, drug discovery, and clinical trial recruitment [PRNewswire; Bounce Watch]. The entity emerged in November 2024 from the merger of IndyGeneUS AI and EncrypGen, repositioning as a biofintech that pairs sequencing infrastructure with token-based data rights management [EINPresswire, November 2024]. Founder and CEO Yusuf Henriques is a U.S. Army combat medic veteran, Howard University biochemistry graduate, and former FDA biologist who previously founded TruGenomix Health [ETC Baltimore; ContactOut, 2026]. Capital to date includes a $1.5M pre-seed led by IsimoVest in November 2021, a separately reported $2M pre-seed, and a seed round led by the Baltimore Development Corporation [Crunchbase; GenomeWeb; The AI Journal]. Recent signals include a patent filing for the Clinico-Genomic Insight Engine and a partnership with Oracle Cloud Infrastructure to launch Africa's first AI×Bio Factory, with a stated ambition to sequence one million genomes by 2030 [PRNewswire; EINPresswire, November 2025].

Data Accuracy: GREEN -- Confirmed by EINPresswire, ETC Baltimore, PRNewswire, and Crunchbase.

Taxonomy Snapshot

Axis	Value
Stage	Seed
Business Model	B2B
Industry / Vertical	Healthtech / Genomics
Technology Type	Biotech / Life Sciences + Blockchain
Geography	North America, expanding to Africa
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding	Seed (at least $3.5M disclosed)

How the Company Got Here

IndyGeneUS Bio was announced in November 2024 as the combination of IndyGeneUS AI and EncrypGen, a blockchain-based platform for genomic data rights [EINPresswire, November 2024]. The company is headquartered in Baltimore and operates out of the Emerging Technology Centers (ETC) Baltimore incubator [ETC Baltimore].

Milestones include a $1.5M pre-seed round led by IsimoVest Venture Capital Partners in November 2021, a separately reported $2M pre-seed, and a seed investment from the Baltimore Development Corporation [Crunchbase; GenomeWeb; The AI Journal]. In 2023 the company joined the Google for Startups Black Founders Fund cohort [Bounce Watch]. In 2025, the company filed a patent for its Clinico-Genomic Insight Engine and announced the Oracle Cloud Infrastructure partnership [PRNewswire; EINPresswire, November 2025]. The company also took first place in the Disabled American Veterans Pitch Competition [ETC Baltimore; The Transition Podcast].

Data Accuracy: GREEN -- Confirmed by EINPresswire, ETC Baltimore, and Crunchbase.

Product and Technology

IndyGeneUS Bio operates a sequencing and biobank layer building a blockchain-encrypted repository of indigenous and diasporic African/Afro-Latin clinical and multi-omics data [Bounce Watch]. The Clinico-Genomic Insight Engine, for which the company filed a patent in 2025, serves as the analytical core of its AI×Bio Factory hub [PRNewswire]. The blockchain element, inherited from EncrypGen, provides a data-rights and consent layer [EINPresswire, November 2024]. The infrastructure is anchored by the Oracle Cloud Infrastructure partnership, targeting one million genomes by 2030 [EINPresswire, November 2025]. A partnership with The Aurum Institute supports precision medicine work in Africa [LinkedIn].

Data Accuracy: YELLOW -- Product narrative is corroborated by PRNewswire, EINPresswire, and Bounce Watch, but operational metrics are not publicly disclosed.

Market Research and Opportunity

Genomic underrepresentation of participants of African ancestry in reference datasets creates demand for IndyGeneUS Bio's biobank [Technical.ly]. The buyer set includes pharmaceutical sponsors running trials in oncology, cardiometabolic disease, and rare disease; African and Caribbean ministries of health; and academic consortia [LinkedIn]. Demand tailwinds include FDA diversity action plan requirements and sovereign interest in domestic genomic infrastructure [EINPresswire, November 2025].

Metric	Value
Stated sequencing target by 2030	1,000,000 genomes
Disclosed pre-seed plus seed capital	$3,500,000

Data Accuracy: YELLOW -- Demand drivers corroborated by Technical.ly and EINPresswire; no third-party TAM figure cited in available sources.

Competitive Landscape

IndyGeneUS Bio operates in a niche of African and Afro-diasporic population genomics paired with blockchain consent. Adjacencies include non-commercial consortia like H3Africa, for-profit population-genomics companies, and broader precision-medicine data layers like Tempus and Genomics England. Competitive edges include the Howard University talent pipeline [Yusuf Henriques Bio, 2026], veteran-owned status for federal contracting [The Transition Podcast], and the Oracle Cloud Infrastructure partnership [EINPresswire, November 2025].

Data Accuracy: ORANGE -- Subject positioning corroborated by PRNewswire and EINPresswire; competitor set inferred from category knowledge as no competitors are named in cited sources.

Opportunity

The headline opportunity

IndyGeneUS Bio aims to become the reference biobank and consent infrastructure for pharmaceutical sponsors satisfying diversity requirements. Evidence includes the Oracle Cloud Infrastructure partnership [EINPresswire, November 2025], the patent filing on the Clinico-Genomic Insight Engine [PRNewswire], and the founder's FDA regulatory background [ContactOut, 2026].

Growth scenarios

Scenario	Catalyst
Pharma cohort contract	First named pharma deal disclosed in 2026 press
Sovereign AI×Bio Factory	Expansion of OCI partnership into a named country deployment
Federal SDVOSB channel	Award announcement on a federal genomics or PTSD program

Data Accuracy: ORANGE -- Scenarios are analyst-constructed from cited partnership and product announcements; outcomes are not forecasts.

Sources

1. [Technical.ly] IndyGeneUS Bio profile | https://technical.ly/company/indygeneus/
2. [Bounce Watch] IndyGeneUS Bio Startup Profile and Investments | https://www.bouncewatch.com/explore/startup/indygeneus-ai-google-for-startups-23
3. [EINPresswire, November 2024] IndyGeneUS Bio: Transforming Longevity through African Genomic Data | https://www.einpresswire.com/article/756814758/indygeneus-bio-transforming-longevity-through-african-genomic-data
4. [EINPresswire, November 2025] IndyGeneUS Bio AI×Bio Factory and Oracle Cloud Infrastructure partnership announcement | https://www.einpresswire.com/article/756814758/indygeneus-bio-transforming-longevity-through-african-genomic-data
5. [ETC Baltimore] ETC-Backed IndyGeneUS Bio Wins Disabled American Veterans Pitch Competition | https://www.etcbaltimore.com/news/etc-backed-indygeneus-bio-wins-disabled-american-veterans-pitch-competition
6. [LinkedIn] IndyGeneUS Bio company page | https://www.linkedin.com/company/indygeneus
7. [PRNewswire] IndyGeneUS Bio Files Patent for Clinico-Genomic Insight Engine | https://www.prnewswire.com/news-releases/indygeneus-bio-files-patent-for-clinico-genomic-insight-engine-advancing-their-aiObio-factory-hub-from-baltimore-to-africa-302658583.html
8. [The AI Journal] IndyGeneUS Bio Files Patent for Clinico-Genomic Insight Engine | https://aijourn.com/indygeneus-bio-files-patent-for-clinico-genomic-insight-engine-advancing-their-aixbio-factory-hub-from-baltimore-to-africa/
9. [me.sh, 2026] Yusuf Henriques profile | https://me.sh/profile/yusuf-henriques
10. [ContactOut, 2026] Yusuf Henriques profile | https://contactout.com/Yusuf-Henriques-3855492
11. [The Transition Podcast] Interview with Yusuf Henriques | https://podcasts.apple.com/us/podcast/how-an-army-combat-medic-is-utilizing-technology-to/id1532812903?i=1000562428111
12. [MIPAD Blog, 2026] He is Yusuf Henriques | https://blog.mipad.org/he-is-yusuf-henriques/
13. [Yusuf Henriques Bio, 2026] Bio - Yusuf Henriques | https://yusufhenriques.com/bio/
14. [MEN Impact Change, 2026] Yusuf Henriques profile | https://menimpactchange.org/yusuf-henriques/
15. [Crunchbase] IndyGeneUS Bio funding profile | https://www.crunchbase.com/organization/indygeneus-ai
16. [GenomeWeb] IndyGeneUS pre-seed coverage | https://www.genomeweb.com/